1. Home
  2. FOXO vs RDHL Comparison

FOXO vs RDHL Comparison

Compare FOXO & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXO
  • RDHL
  • Stock Information
  • Founded
  • FOXO 2019
  • RDHL 2009
  • Country
  • FOXO United States
  • RDHL Israel
  • Employees
  • FOXO N/A
  • RDHL N/A
  • Industry
  • FOXO Retail: Computer Software & Peripheral Equipment
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXO Technology
  • RDHL Health Care
  • Exchange
  • FOXO Nasdaq
  • RDHL Nasdaq
  • Market Cap
  • FOXO 4.9M
  • RDHL 6.8M
  • IPO Year
  • FOXO N/A
  • RDHL N/A
  • Fundamental
  • Price
  • FOXO $0.22
  • RDHL $5.29
  • Analyst Decision
  • FOXO
  • RDHL
  • Analyst Count
  • FOXO 0
  • RDHL 0
  • Target Price
  • FOXO N/A
  • RDHL N/A
  • AVG Volume (30 Days)
  • FOXO 8.6M
  • RDHL 10.5K
  • Earning Date
  • FOXO 11-19-2024
  • RDHL 04-07-2025
  • Dividend Yield
  • FOXO N/A
  • RDHL N/A
  • EPS Growth
  • FOXO N/A
  • RDHL N/A
  • EPS
  • FOXO N/A
  • RDHL N/A
  • Revenue
  • FOXO $1,341,000.00
  • RDHL $3,707,000.00
  • Revenue This Year
  • FOXO N/A
  • RDHL $224.90
  • Revenue Next Year
  • FOXO N/A
  • RDHL $82.69
  • P/E Ratio
  • FOXO N/A
  • RDHL N/A
  • Revenue Growth
  • FOXO 196.03
  • RDHL N/A
  • 52 Week Low
  • FOXO $0.13
  • RDHL $5.20
  • 52 Week High
  • FOXO $1.30
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • FOXO 43.64
  • RDHL 33.91
  • Support Level
  • FOXO $0.20
  • RDHL $5.20
  • Resistance Level
  • FOXO $0.25
  • RDHL $5.50
  • Average True Range (ATR)
  • FOXO 0.02
  • RDHL 0.27
  • MACD
  • FOXO 0.00
  • RDHL -0.03
  • Stochastic Oscillator
  • FOXO 34.46
  • RDHL 7.10

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: